Antheia Achieves Major Commercial Milestone

Company’s first full-scale fermentation run reinforces commercial viability for a robust pipeline of Biosynthetic KSMs and APIs MENLO PARK, Calif., Aug. 24, 2023 /PRNewswire/ — Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, today…

Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks